Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
Gastroenterology
|
January 20, 2024
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma
Max M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, et al.
The Lancet. Oncology
|
May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker, Berend R Beumer, Eran Sadot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Annie A Wu, Katherine M Bever, Won Jin Ho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2022
MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial
Hyun Kim, Jeffrey R Olsen, Olga L Green, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension
Henry G Bone, Roland Chapurlat, Maria-Luisa Brandi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
December 6, 2016
Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study
David G Brauer, Matthew S Strand, Dominic E Sanford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer
Dung T Le, Andrea Wang-Gillam, Vincent Picozzi, et al.
Cancer Medicine
|
July 27, 2019
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
Zishuo Ian Hu, Johanna C Bendell, Andrea Bullock, et al.
Clinical Colorectal Cancer
|
May 18, 2021
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
Hyun Kim, Katrina Pedersen, Jeffrey R Olsen, et al.
Journal for Immunotherapy of Cancer
|
November 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
Kevin Conlon, Dionysios C Watson, Thomas A Waldmann, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
Gastroenterology
|
January 20, 2024
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma
Max M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, et al.
The Lancet. Oncology
|
May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker, Berend R Beumer, Eran Sadot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Annie A Wu, Katherine M Bever, Won Jin Ho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2022
MR-Guided Radiation Therapy With Concurrent Gemcitabine/Nab-Paclitaxel Chemotherapy in Inoperable Pancreatic Cancer: A TITE-CRM Phase I Trial
Hyun Kim, Jeffrey R Olsen, Olga L Green, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension
Henry G Bone, Roland Chapurlat, Maria-Luisa Brandi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
December 6, 2016
Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study
David G Brauer, Matthew S Strand, Dominic E Sanford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer
Dung T Le, Andrea Wang-Gillam, Vincent Picozzi, et al.
Cancer Medicine
|
July 27, 2019
A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
Zishuo Ian Hu, Johanna C Bendell, Andrea Bullock, et al.
Clinical Colorectal Cancer
|
May 18, 2021
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
Hyun Kim, Katrina Pedersen, Jeffrey R Olsen, et al.
Journal for Immunotherapy of Cancer
|
November 20, 2021
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
Kevin Conlon, Dionysios C Watson, Thomas A Waldmann, et al.
Page
of 17